NICE issued advice last week on the fracture prevention treatment denosumab, the diabetes drug...The institute backed denosumab (Prolia) for some postmenopausal women at increased risk of osteoporotic fractures if other NHS treatments are unsuitable.
NICE has also issued final guidance approving ...
, NICE says.
For stroke patients, this should be recommended only when clopidogrel is not tolerated ...
GPs have been barred from prescribing drugs recommended by NICE because PCTs have 'blacklisted...A GP investigation revealed that one in four PCTs now blacklist drugs backed by NICE. Drugs ...
or not effective enough.
The NHS Constitution gives patients the right to receive any drug recommended in NICE ...
in NICE appraisals, and a further five drugs backed in NICE clinical guidance, have been blacklisted ...
21 Oct 2010
issued by NICE....licensed for limited use in the treatment of rheumatoid arthritis and ankylosing spondylitis.
NICE has ...
available options. A spokesman said: 'NICE recommends adalimumab, etanercept and infliximab ...
that golimumab was not the most cost-effective of the available options currently recommended by NICE.'
A ...
04 Nov 2010
| by Colin Cooper
to NICE guidance....) for children under the age of 12 in the NHS in England.
In its guidance , NICE said more than a fifth ...
the minimum age for management of the condition.
NICE deputy chairman Dr Gillian Leng said: 'Our clinical ...
will be available to children under seven years, who may have previously been excluded from these services.'
NICE ...
04 Nov 2010
| by Tom Moberly
Economist warns against NICE becoming a 'library' of evidence....Widening NICE's role risks emasculating the organisation and introducing inefficiency in the NHS, a leading health economist has warned.
The DoH revealed in September that NICE's role will move ...
effectiveness.
Professor Adrian Towse, director of the Office of Health Economics, said NICE must change ...
NHS patients wait more than five years to receive new medicines because NICE misses its own...The Office for Health Economics found that NICE missed its 301-day target for individual medicines in 77% of cases in the past decade. NICE also breached a 420-day target for multiple drugs in 81% of its appraisals. Appeals and legal challenges outside of NICE's control added to the delays ...
11 Nov 2010
| by Editorial
Last week, the national media finally caught up with GP newspaper's September exclusive that NICE...to break the news to patients that they can't have the drugs they want?
Why let GPs take on NICE's drug ...
The drive to control NHS costs has led many PCTs to 'blacklist' drugs recommended by NICE, a GP ...
been appraised by NICE.
West London GP and British Cardiology Society member Dr Sarah Jarvis ...
networks to make decisions on whether new drugs that have not yet been assessed by NICE should be made ...
that in other countries, he said.
Dr Barker said NICE should recognise that when a drug is launched there may ...
The latest advice from the NICE-run National Prescribing Centre (NPC) is a case in point. Working ...
that PCTs were 'blacklisting' drugs approved by NICE - barring GPs from prescribing them - to cut costs ...
of ezetimibe and high-cost statins in line with NICE guidance.
Type 2 diabetes - Consider risks ...